Re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285–293 von Dong, Chen, Chen, Sung-Lang, Sung, Wen-Wei

Volltext

Reply to Carlos G. Wambier and Gerard J. Nau’s Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285–93. Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients: Still No Positive Effect of Enzalutamide for Hospitalized COVID-19 Patients von Welén, Karin, Rosendal, Ebba, Freyhult, Eva, Oh, William K., Gisslén, Magnus, Ahlm, Clas, Connolly, Anne-Marie Fors, Överby, Anna K., Josefsson, Andreas

Volltext

Re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285–93: Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients von Wambier, Carlos G., Nau, Gerard J.

Volltext

Reply to Carlos G. Wambier and Gerard J. Nau’s Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285–93. Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients von Welén, Karin, Rosendal, Ebba, Freyhult, Eva, Oh, William K., Gisslén, Magnus, Ahlm, Clas, Connolly, Anne-Marie Fors, Överby, Anna K., Josefsson, Andreas

Volltext

Re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285–93 von Wambier, Carlos G., Nau, Gerard J.

Volltext

Re: Chen Dong, Sung-Lang Chen, and Wen-Wei Sung’s Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285–93 von Welen, Karin, Rosendal, Ebba, Freyhult, Eva, Fors Connolly, Anne-Marie, Överby, Anna K., Josefsson, Andreas

Volltext

HIV-1 infection and cognitive impairment in the cART era: a review von SCHOUTEN, Judith, CINQUE, Paola, GISSLEN, Magnus, REISS, Peter, PORTEGIES, Peter

Volltext

Cohort profile: a longitudinal study of HIV infection in the central nervous system with focus on cerebrospinal fluid – the Gothenburg HIV CSF Study Cohort von Hagberg, Lars, Gisslén, Magnus

Volltext

Antiretroviral Treatment of Acute HIV Infection Normalizes Levels of Cerebrospinal Fluid Markers of Central Nervous System (CNS) Inflammation: A Consequence of a Reduced CNS Reserv... von Gisslén, Magnus, Hunt, Peter W.

Volltext

The ratio of cardiac troponin T to troponin I may indicate non-necrotic troponin release among COVID-19 patients von Hammarsten, Ola, Ljungqvist, Pontus, Redfors, Björn, Wernbom, Mathias, Widing, Hannes, Lindahl, Bertil, Salahuddin, Sabin, Sammantar, Ruwayda, Jha, Sandeep, Ravn-Fischer, Annica, Brink, Magnus, Gisslen, Magnus

Volltext

TTCOV19: timing of tracheotomy in SARS-CoV-2-infected patients: a multicentre, single-blinded, randomized, controlled trial von Eeg-Olofsson, Måns, Pauli, Nina, Hafsten, Louise, Jacobsson, Josephine, Lundborg, Christopher, Brink, Magnus, Larsson, Helen, Lindell, Ellen, Löwhagen, Karin, Gisslén, Magnus, Bergquist, Henrik

Volltext

Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19 von Kanberg, Nelly, Ashton, Nicholas J., Andersson, Lars-Magnus, Yilmaz, Aylin, Lindh, Magnus, Nilsson, Staffan, Price, Richard W., Blennow, Kaj, Zetterberg, Henrik, Gisslén, Magnus

Volltext

Reply to Carlos G. Wambier and Gerard J. Nau's Letter to the Editor re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.12.013. Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients: Still No Positive Effect of Enzalutamide for Hospitalized COVID-19 Patients von Welén, Karin, Rosendal, Ebba, Freyhult, Eva, Oh, William K, Gisslén, Magnus, Ahlm, Clas, Connolly, Anne-Marie Fors, Överby, Anna K, Josefsson, Andreas

Volltext

Antiretroviral drug treatment of CNS HIV-1 infection von YILMAZ, Aylin, PRICE, Richard W, GISSLEN, Magnus

Volltext

Proteomic blood profiling in mild, severe and critical COVID-19 patients von Patel, Hamel, Ashton, Nicholas J., Dobson, Richard J. B., Andersson, Lars-Magnus, Yilmaz, Aylin, Blennow, Kaj, Gisslen, Magnus, Zetterberg, Henrik

Volltext

Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders von Marklund, Emelie, Leach, Susannah, Axelsson, Hannes, Nyström, Kristina, Norder, Heléne, Bemark, Mats, Angeletti, Davide, Lundgren, Anna, Nilsson, Staffan, Andersson, Lars-Magnus, Yilmaz, Aylin, Lindh, Magnus, Liljeqvist, Jan-Åke, Gisslén, Magnus

Volltext

CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series von Edén, Arvid, Kanberg, Nelly, Gostner, Johanna, Fuchs, Dietmar, Hagberg, Lars, Andersson, Lars-Magnus, Lindh, Magnus, Price, Richard W., Zetterberg, Henrik, Gisslén, Magnus

Volltext

Surveillance of wastewater revealed peaks of SARS-CoV-2 preceding those of hospitalized patients with COVID-19 von Saguti, Fredy, Magnil, Ellen, Enache, Lucica, Churqui, Marianela Patzi, Johansson, Anette, Lumley, Douglas, Davidsson, Fredrik, Dotevall, Leif, Mattsson, Ann, Trybala, Edward, Lagging, Martin, Lindh, Magnus, Gisslén, Magnus, Brezicka, Thomas, Nyström, Kristina, Norder, Heléne

Volltext

Serum neopterin levels in relation to mild and severe COVID-19 von Robertson, Josefina, Gostner, Johanna M, Nilsson, Staffan, Andersson, Lars-Magnus, Fuchs, Dietmar, Gisslen, Magnus

Volltext

Sweden, the first country to achieve the Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) 90‐90‐90 continuum of HIV care targets von Gisslén, M, Svedhem, V, Lindborg, L, Flamholc, L, Norrgren, H, Wendahl, S, Axelsson, M, Sönnerborg, A

Volltext